Symptom Changes in Pediatric Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Receiving Leniolisib
IntroductionActivated Phosphoinositide 3-Kinase Delta Syndrome (APDS) is a rare disease characterized by progressive symptoms that begin early in life, including lymphoproliferation, recurrent and persistent infections, and early mortality compared with the global population. Delayed diagnosis and i...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Rockefeller University Press
2026-05-01
|
| Schriftenreihe: | Journal of Human Immunity |
| Online-Zugang: | https://rupress.org/jhi/article/2/CIS2026/eCIS2026abstract.105/281941/Symptom-Changes-in-Pediatric-Patients-with |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
